Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer

clinical trial

Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT02151760

P6099clinical trial phasephase I clinical trialQ5452194
P17countryUnited States of AmericaQ30
P582end time2020-04-01
P921main subjectmetastatic prostate carcinomaQ55779807
P4135maximum age100
P2899minimum age18
P1132number of participants37
P6153research siteJohns Hopkins UniversityQ193727
P580start time2014-05-01
P8363study typeinterventional studyQ78089383
P1476titleStudy of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer

Search more.